Biodesix
BDSX

Biodesix (BDSX) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
TD CowenMaintainedBuy$40.00 from $30.00Oct 13, 2026
HC Wainwright & Co.MaintainedBuy$38.00 from $27.00Sep 25, 2026
Canaccord GenuityMaintainedBuy$35.00 from $27.00Aug 10, 2026
HC Wainwright & Co.MaintainedBuy$27.00 from $26.00Aug 6, 2026
Roth CapitalInitiated CoverageBuy$32.00Jun 25, 2026
Canaccord GenuityMaintainedBuy$27.00 from $22.00Jun 18, 2026
HC Wainwright & Co.Initiated CoverageBuy$26.00Jun 15, 2026
Canaccord GenuityMaintainedBuy$22.00 from $20.00May 5, 2026
William BlairUpgradedMarket Perform → Outperform—Feb 27, 2026
Canaccord GenuityMaintainedBuy$20.00Feb 17, 2026
Canaccord GenuityMaintainedBuy$20.00 from $30.00Sep 19, 2025
ScotiabankMaintainedSector Outperform$2.00 from $3.00May 21, 2025
William BlairDowngradedOutperform → Market Perform—May 14, 2025
Canaccord GenuityMaintainedBuy$1.50 from $2.50May 14, 2025
Lake StreetMaintainedBuy$2.00 from $3.00May 14, 2025
Craig-HallumMaintainedBuy$1.50 from $3.00May 14, 2025
Canaccord GenuityMaintainedBuy$2.50 from $3.50Apr 29, 2025
ScotiabankInitiated CoverageSector Outperform$3.00Sep 16, 2024
Craig-HallumInitiated CoverageBuy$3.00Jul 26, 2024
TD CowenInitiated CoverageBuy$2.80May 13, 2024

Frequently asked questions

  • What is the latest analyst rating on BDSX?

    On Oct 13, 2026, TD Cowen maintained Biodesix at Buy with a price target of $40.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.